Skip to main content

Table 1 Demographics of nominal group participants (n = 45)

From: Gout and comorbidity: a nominal group study of people with gout

  Number (percentage)a
Age in years, mean (SD) 60.9 (10.7)
Sex, male (%) 28 (62%)
Disease duration in years, mean (SD) 14.9 (12)
Race/ethnicity
 White 22 (49%)
 African-American 20 (45%)
 Hispanic 1 (2%)
 Asian 2 (4%)
Education level
 Less than high school 1 (2%)
 High school graduate 7 (15%)
 Some college or technical/vocational training 16 (35%)
 College Bachelor degree and beyond 21 (46%)
Marital status
 Divorced 7 (15%)
 Domestic partnership 1 (2%)
 Married 23 (51%)
 Separated 4 (9%)
 Single 7 (15%)
 Widowed 3 (7%)
Employment statusb
 Employed 5 (11%)
 Homemaker 1 (2%)
 Retired 21 (46%)
 Self-employed 5 (11%)
 Unable to work 12 (26%)
Current medications to treat goutc
 Allopurinol 8 (17%)
 Allopurinol, pain medication (NSAID or analgesic or narcotic) 3 (7%)
 Allopurinol, colchicine (with/without pain medication) 13 (28%)
 Allopurinol, colchicine, prednisone (with/without pain medication) 5 (11%)
 Colchicine alone 4 (9%)
 Allopurinol, febuxostat, colchicine, prednisone, pain medication 2 (4%)
 Febuxostat (with/without colchicine and/or prednisone) 7 (15%)
 None 1 (2%)
Current use of natural supplementsd
 None 15 (33%)
 Cherries 1 (2%)
 Cherry extract or concentrate 5 (11%)
 Cherry juice 6 (13%)
 Multivitamin 8 (17%)
 Vitamin C 3 (7%)
 Others 2 (4%)
Number of gout flares in the last 6 monthse
0 12 (36%)
1 7 (21%)
2 1 (3%)
3–5 5 (15%)
  ≥ 6 7 (21%)
  1. aNumber (percentage) unless otherwise specified
  2. bOne person did not respond to this question
  3. cTwo people did not respond to this question
  4. dSix people did not respond to this question
  5. eOne person did not respond to this question; since the question was added from the third nominal group onwards, the number of total responses was 33